Marginal zone lymphoma (low-grade B-cell lymphoma of mucosa-associated lymphoid tissue type) of skin and subcutaneous tissue: a study of 15 patients.

PubWeight™: 1.45‹?› | Rank: Top 5%

🔗 View Article (PMID 8712288)

Published in Am J Surg Pathol on August 01, 1996

Authors

E M Bailey1, J A Ferry, N L Harris, M C Mihm, J O Jacobson, L M Duncan

Author Affiliations

1: Department of Pathology, Massachusetts General Hospital, Boston 02114-2698, USA.

Articles by these authors

The genome sequence of Drosophila melanogaster. Science (2000) 74.32

Comparative genomics of the eukaryotes. Science (2000) 26.62

Report of an international workshop to standardize response criteria for non-Hodgkin's lymphomas. NCI Sponsored International Working Group. J Clin Oncol (1999) 17.43

The histogenesis and biologic behavior of primary human malignant melanomas of the skin. Cancer Res (1969) 13.27

Genome annotation assessment in Drosophila melanogaster. Genome Res (2000) 11.77

Interleukin-2 receptor alpha chain regulates the size and content of the peripheral lymphoid compartment. Immunity (1995) 6.91

Bovine reservoir for verotoxin-producing Escherichia coli O157:H7. Lancet (1987) 5.63

Splice junctions, branch point sites, and exons: sequence statistics, identification, and applications to genome project. Methods Enzymol (1990) 5.35

Prognostic value of tumor infiltrating lymphocytes in the vertical growth phase of primary cutaneous melanoma. Cancer (1996) 4.46

Tumours of histiocytes and accessory dendritic cells: an immunohistochemical approach to classification from the International Lymphoma Study Group based on 61 cases. Histopathology (2002) 4.22

Mantle cell lymphoma. A proposal for unification of morphologic, immunologic, and molecular data. Am J Surg Pathol (1992) 4.04

Long-term results of a multi-institutional randomized trial comparing prognostic factors and surgical results for intermediate thickness melanomas (1.0 to 4.0 mm). Intergroup Melanoma Surgical Trial. Ann Surg Oncol (2000) 3.42

Uterine papillary serous carcinoma: patterns of metastatic spread. Gynecol Oncol (1994) 2.93

GLUT1: a newly discovered immunohistochemical marker for juvenile hemangiomas. Hum Pathol (2000) 2.86

Role of the clotting system in cell-mediated hypersensitivity. I. Fibrin deposition in delayed skin reactions in man. J Exp Med (1973) 2.75

Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg (1996) 2.68

The classification of malignant melanoma and its histologic reporting. Cancer (1973) 2.67

Nonfamilial cutaneous melanoma incidence in women associated with sun exposure before 20 years of age. Pediatrics (1989) 2.61

Atypical Spitz nevi/tumors: lack of consensus for diagnosis, discrimination from melanoma, and prediction of outcome. Hum Pathol (1999) 2.50

Common and uncommon melanocytic nevi and borderline melanomas. Semin Oncol (1975) 2.36

Melanoma in children. N Engl J Med (1995) 2.35

How many men who have sex with men and female sex workers live in El Salvador? Using respondent-driven sampling and capture-recapture to estimate population sizes. Sex Transm Infect (2011) 2.31

Benign cutaneous adnexal tumors with combined folliculosebaceous, apocrine, and eccrine differentiation. Clinicopathologic and immunohistochemical study of eight cases. Am J Dermatopathol (1996) 2.30

Hodgkin's disease and Epstein-Barr virus. Altered antibody pattern before diagnosis. N Engl J Med (1989) 2.25

Viral genome organizer: a system for analyzing complete viral genomes. Virus Res (2000) 2.24

Transplacental transmission of natural-killer-cell lymphoma. N Engl J Med (1999) 2.23

Efficacy of 2-cm surgical margins for intermediate-thickness melanomas (1 to 4 mm). Results of a multi-institutional randomized surgical trial. Ann Surg (1993) 2.08

Long-term results of a prospective surgical trial comparing 2 cm vs. 4 cm excision margins for 740 patients with 1-4 mm melanomas. Ann Surg Oncol (2001) 2.06

PRAD1, a candidate BCL1 oncogene: mapping and expression in centrocytic lymphoma. Proc Natl Acad Sci U S A (1991) 2.04

Carcinomas of the urinary bladder simulating malignant lymphoma. A report of five cases. Am J Surg Pathol (1991) 2.00

Lymphomas of the breast: pathology and clinical behavior. Semin Oncol (1999) 2.00

Alternative birth positions. Can Fam Physician (1988) 1.97

Kimura's disease and angiolymphoid hyperplasia with eosinophilia: two distinct histopathological entities. J Cutan Pathol (1987) 1.92

Automatic differentiation of melanoma from melanocytic nevi with multispectral digital dermoscopy: a feasibility study. J Am Acad Dermatol (2001) 1.91

Nonepidermal origin of malignant melanoma associated with a giant congenital nevocellular nevus. Plast Reconstr Surg (1981) 1.86

Dermal dendritic melanocytic proliferations: an update. Histopathology (2004) 1.84

Narrower margins for clinical stage I malignant melanoma. N Engl J Med (1982) 1.82

Primary melanoma of the skin: recognition and management. J Am Acad Dermatol (1980) 1.82

Marginal zone B-cell lymphoma of the salivary gland arising in chronic sclerosing sialadenitis (Küttner tumor). Am J Surg Pathol (2001) 1.80

A new immunologic marker for human Langerhans cells. N Engl J Med (1981) 1.79

A unique microvascular phenotype shared by juvenile hemangiomas and human placenta. Arch Dermatol (2001) 1.77

Melasma: a clinical, light microscopic, ultrastructural, and immunofluorescence study. J Am Acad Dermatol (1981) 1.76

Basophilic leukocytes in allergic contact dermatitis. J Exp Med (1972) 1.75

Diffuse low-grade B-cell lymphomas. Four clinically distinct subtypes defined by a combination of morphologic and immunophenotypic features. Am J Clin Pathol (1993) 1.75

Rejection of first-set skin allografts in man. the microvasculature is the critical target of the immune response. J Exp Med (1979) 1.74

Characterization of Langerhans cells by the use of monoclonal antibodies. Lab Invest (1981) 1.73

CD5+ extranodal marginal zone B-cell (MALT) lymphoma. A low grade neoplasm with a propensity for bone marrow involvement and relapse. Am J Clin Pathol (1996) 1.72

Prognostic factors for melanoma patients with lesions 0.76 - 1.69 mm in thickness. An appraisal of "thin" level IV lesions. Ann Surg (1982) 1.72

Dysplastic melanocytic nevi: a reproducible histologic definition emphasizing cellular morphology. Mod Pathol (1989) 1.71

Pilomatrix carcinoma or calcifying epitheliocarcinoma of Malherbe: a case report and review of literature. Cancer (1980) 1.70

Morphology of delayed-type hypersensitivity reactions in man. II. Ultrastructural alterations affecting the microvasculature and the tissue mast cells. Lab Invest (1976) 1.70

Morphology of delayed type hypersensitivity reactions in man. I. Quantitative description of the inflammatory response. Lab Invest (1974) 1.68

Expression of bcl-6 and CD10 in primary mediastinal large B-cell lymphoma: evidence for derivation from germinal center B cells? Am J Surg Pathol (2001) 1.68

Ocular adnexal lymphoma. A clinicopathologic study with identification of lymphomas of mucosa-associated lymphoid tissue type. Ophthalmology (1995) 1.68

Lentigo maligna and lentigo-maligna melanoma. Am J Pathol (1969) 1.68

Squamoid eccrine ductal carcinoma. Histopathology (1997) 1.67

A revised European-American classification of lymphoid neoplasms proposed by the International Lymphoma Study Group. A summary version. Am J Clin Pathol (1995) 1.67

The clinical diagnosis, classification and histogenetic concepts of the early stages of cutaneous malignant melanomas. N Engl J Med (1971) 1.65

Lymphoma of the kidney. A report of 11 cases. Am J Surg Pathol (1995) 1.65

Posttransplant lymphoproliferative disorders: summary of Society for Hematopathology Workshop. Semin Diagn Pathol (1997) 1.64

Lymphoid infiltrates of the stomach. Evaluation of histologic criteria for the diagnosis of low-grade gastric lymphoma on endoscopic biopsy specimens. Am J Surg Pathol (1990) 1.63

Studies on the cellular origin of neurothekeoma: clinical, light microscopic, immunohistochemical, and ultrastructural observations. J Am Acad Dermatol (1991) 1.59

Granulocytic sarcoma of the female genital tract: a clinicopathologic study of 11 cases. Am J Surg Pathol (1997) 1.57

Histopathologic diagnosis of dysplastic nevi: concordance among pathologists convened by the World Health Organization Melanoma Programme. Hum Pathol (1991) 1.54

Pathology with clinical correlations of primary central nervous system non-Hodgkin's lymphoma. The Massachusetts General Hospital experience 1958-1989. Cancer (1994) 1.52

Extranodal lymphoid infiltrates and mucosa-associated lymphoid tissue (MALT). A unifying concept. Am J Surg Pathol (1991) 1.51

Bullous dermatosis of hemodialysis. Ann Intern Med (1975) 1.47

The natural break points for primary-tumor thickness in clinical Stage I melanoma. N Engl J Med (1981) 1.45

World Health Organization classification of neoplastic diseases of the hematopoietic and lymphoid tissues. A progress report. Am J Clin Pathol (1999) 1.45

Plasma cell myeloma with cleaved, multilobated, and monocytoid nuclei. Am J Clin Pathol (1990) 1.44

Actin-binding protein expression in benign and malignant melanocytic proliferations. Hum Pathol (1994) 1.44

Mucoepidermoid lung tumors. Ann Thorac Surg (1989) 1.43

Origin of cutaneous melanoma in a congenital dysplastic nevus spilus. Arch Dermatol (1990) 1.43

Early melanoma. Histologic terms. Am J Dermatopathol (1991) 1.43

Acral lentiginous melanoma (including in situ melanoma) arising in association with naevocellular naevi. Melanoma Res (1996) 1.42

The bcl-2 gene is rearranged in many diffuse B-cell lymphomas. Blood (1988) 1.42

Malignant lymphoma of the testis, epididymis, and spermatic cord. A clinicopathologic study of 69 cases with immunophenotypic analysis. Am J Surg Pathol (1994) 1.42

Adjuvant high-dose interferon alfa-2b in patients with high-risk melanoma. Cancer J (2000) 1.41

Topical axitinib suppresses angiogenesis pathways induced by pulsed dye laser. Br J Dermatol (2014) 1.40

Myeloperoxidase detection by three-color flow cytometry and by enzyme cytochemistry in the classification of acute leukemia. Am J Clin Pathol (1998) 1.40

Standardization of the surgical pathology report. Mod Pathol (1992) 1.38

A prognostic model for clinical stage I melanoma of the upper extremity. The importance of anatomic subsites in predicting recurrent disease. Ann Surg (1981) 1.38

Expression of the activation antigen, 4F2, by non-Hodgkin's lymphomas of B-cell phenotype. Cancer (1990) 1.38

Malignant lymphoma and granulocytic sarcoma of the uterus and vagina. A clinicopathologic analysis of 27 cases. Cancer (1984) 1.38

Prognostic factors for patients with clinical stage I melanoma of intermediate thickness (1.51 - 3.39 mm). A conceptual model for tumor growth and metastasis. Ann Surg (1982) 1.38

Breast lymphoma. A B-cell spectrum including the low grade B-cell lymphoma of mucosa associated lymphoid tissue. Am J Surg Pathol (1993) 1.37

Congenital melanocytic nevi of the small and garment type. Clinical, histologic, and ultrastructural studies. Hum Pathol (1973) 1.36

Bullous pemphigoid, an ultrastructural study of the inflammatory response: eosinophil, basophil and mast cell granule changes in multiple biopsies from one patient. J Invest Dermatol (1982) 1.35

Angiogenesis and tumor progression of melanoma. Quantification of vascularity in melanocytic nevi and cutaneous malignant melanoma. Lab Invest (1992) 1.34

Breakpoints of the t(11;18)(q21;q21) in mucosa-associated lymphoid tissue (MALT) lymphoma lie within or near the previously undescribed gene MALT1 in chromosome 18. Cancer Res (1999) 1.34

Lymphoid infiltrates of the orbit and conjunctiva. A morphologic and immunophenotypic study of 99 cases. Am J Surg Pathol (1989) 1.34

Malignant melanoma. Prognostic significance of "microscopic satellites" in the reticular dermis and subcutaneous fat. Ann Surg (1981) 1.34